Jeremy Veenstra-VanderWeele talks routes to treatment

The Presenter

Jeremy Veenstra-VanderWeele

Associate Professor of Psychiatry, Pediatrics, and Pharmacology, Vanderbilt University School of Medicine

Jeremy Veenstra-VanderWeele uses molecular and translational neuroscience research tools in the pursuit of new treatments for autism.

See Full Bio

On 25 June, Jeremy Veenstra-VanderWeele laid out two conceptual paths forward for developing effective autism drugs — one that focuses on the total group of people affected by autism but that might only provide modest relief, and another that could be transformative but focuses on a subset of individuals with the disorder.

Veenstra-VanderWeele is medical director of the Treatment and Research Institute for Autism Spectrum Disorders at Vanderbilt University in Nashville, Tennessee.

You can watch a complete replay of the webinar above.

Use the comments section below to submit questions we didn’t have time to discuss during the Q&A session or to pose follow-up questions for Veenstra-VanderWeele.

Press Policy

The Spectrum Webinar Series aims to facilitate the free exchange of ideas among autism researchers, including discussion of published and unpublished research, hypotheses and results. Members of the press may report information presented during a Spectrum webinar only if that material has already been published elsewhere or they have first obtained express written consent from the presenter.

About Webinars

Presentations by leading experts that showcase new findings, useful techniques and emerging topics in autism research. We invite questions before and during the presentations in the Comments section.

Spectrum: Autism Research News

Jeremy Veenstra-VanderWeele talks routes to treatment